Viral infection and atherosclerosis

Abstract

Several risk factors have been described for the pathogenesis of atherosclerosis. Infectious diseases are suggested to be a causative factor, and some viruses have been studied for their relation with atherosclerotic diseases. Studies report two hypotheses, direct and indirect effects, for the role of viral infections in atherogenesis. Viruses are able to initiate atherosclerosis by two different pathways. They can exert their direct effects on atherogenesis by infecting vascular cells and then inducing inflammation in the endothelium and smooth muscle cells. Alternatively, they can also apply indirect effects by infecting non-vascular cells and inducing systemic inflammation. In this review, we consider the available data about the effects and correlations of DNA and RNA viruses on atherosclerosis.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F, Centers for Disease C, Prevention, American Heart A (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511. https://doi.org/10.1161/01.CIR.0000052939.59093.45

    Article  PubMed  Google Scholar 

  2. 2.

    Merz CNB, Johnson BD, Sharaf BL, Bittner V, Berga SL, Braunstein GD, Hodgson TK, Matthews KA, Pepine CJ, Reis SE (2003) Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol 41(3):413–419. https://doi.org/10.1016/S0735-1097(02)02763-8

    CAS  Article  Google Scholar 

  3. 3.

    O’Connor S, Taylor C, Campbell LA, Epstein S, Libby P (2001) Potential infectious etiologies of atherosclerosis: a multifactorial perspective. Emerg Infect Dis 7(5):780–788. https://doi.org/10.3201/eid0705.010503

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Campbell LA, Rosenfeld ME (2015) Infection and atherosclerosis development. Arch Med Res 46(5):339–350. https://doi.org/10.1016/j.arcmed.2015.05.006

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet 350(9075):430–436. https://doi.org/10.1016/S0140-6736(97)03079-1

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Libby P, Egan D, Skarlatos S (1997) Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 96(11):4095–4103. https://doi.org/10.1161/01.CIR.96.11.4095

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Mattila K, Valtonen V, Nieminen MS, Asikainen S (1998) Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 26(3):719–734. https://doi.org/10.1086/514570

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Estein S, Zhou Y, Zhu J (1999) Infection and atherosclerosis: emerging mechanism paradigms. Circulation 100:e20–e28

    Google Scholar 

  9. 9.

    Hajjar DP (1991) Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes. Am J Pathol 139(6):1195–1211

    CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Fabricant CG, Fabricant J (1999) Atherosclerosis induced by infection with Marek’s disease herpesvirus in chickens. Am Heart J 138(5):S465–S468. https://doi.org/10.1016/S0002-8703(99)70276-0

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Benditt EP, Barrett T, McDougall JK (1983) Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci U S A 80(20):6386–6389. https://doi.org/10.1073/pnas.80.20.6386

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Weber C, Noels H (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17(11):1410–1422. https://doi.org/10.1038/nm.2538

    CAS  Article  Google Scholar 

  13. 13.

    Hsich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE (2001) Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 156(1):23–28. https://doi.org/10.1016/S0021-9150(00)00608-0

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Hendrix MG, Salimans MM, van Boven CP, Bruggeman CA (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136(1):23–28

    CAS  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Chiu B, Viira E, Tucker W, Fong IW (1997) Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96(7):2144–2148. https://doi.org/10.1161/01.CIR.96.7.2144

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Horváth R, Černý J, Benedík JRJ, Hökl J, Jelínková I, Benedík J (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 16(1):17–24. https://doi.org/10.1016/S1386-6532(99)00064-5

    Article  PubMed  Google Scholar 

  17. 17.

    Burnett MS, Gaydos CA, Madico GE, Glad SM, Paigen B, Quinn TC, Epstein SE (2001) Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 183(2):226–231. https://doi.org/10.1086/317938

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Vliegen I, Duijvestijn A, Stassen F, Bruggeman C (2004) Murine cytomegalovirus infection directs macrophage differentiation into a pro-inflammatory immune phenotype: implications for atherogenesis. Microbes Infect 6(12):1056–1062. https://doi.org/10.1016/j.micinf.2004.05.020

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Etingin OR, Silverstein RL, Hajjar DP (1991) Identification of a monocyte receptor on herpesvirus-infected endothelial cells. Proc Natl Acad Sci U S A 88(16):7200–7203. https://doi.org/10.1073/pnas.88.16.7200

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Chirathaworn C, Pongpanich A, Poovorawan Y (2004) Herpes simplex virus 1 induced LOX-1 expression in an endothelial cell line, ECV 304. Viral Immunol 17(2):308–314. https://doi.org/10.1089/0882824041310531

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ (1987) Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis. J Clin Invest 80(5):1317–1321. https://doi.org/10.1172/JCI113208

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Shi Y, Tokunaga O (2002) Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 52(1):31–39. https://doi.org/10.1046/j.1440-1827.2002.01312.x

    Article  PubMed  Google Scholar 

  23. 23.

    Sutherland MR, Raynor CM, Leenknegt H, Wright JF, Pryzdial EL (1997) Coagulation initiated on herpesviruses. Proc Natl Acad Sci U S A 94(25):13510–13514. https://doi.org/10.1073/pnas.94.25.13510

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Sun Y, Pei W, Wu Y, Jing Z, Zhang J, Wang G (2004) Herpes simplex virus type 2 infection is a risk factor for hypertension. Hypertens Res 27(8):541–544. https://doi.org/10.1291/hypres.27.541

    Article  PubMed  Google Scholar 

  25. 25.

    Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J, AtheroGene I (2002) Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105(1):15–21. https://doi.org/10.1161/hc0102.101362

    Article  PubMed  Google Scholar 

  26. 26.

    Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, Hafner G, Prellwitz W, Schlumberger W, Meyer J (2002) Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33(11):2581–2586. https://doi.org/10.1161/01.STR.0000034789.82859.A4

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    KOTRONIAS D, KAPRANOS N (2005) Herpes simplex virus as a determinant risk factor for coronary artery atherosclerosis and myocardial infarction. In Vivo 19(2):351–357

    PubMed  Google Scholar 

  28. 28.

    Ibrahim AI, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, Kindermann I, Boehm M, Roemer K, Mueller-Lantzsch N, Gartner BC (2005) Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 32(1):29–32. https://doi.org/10.1016/j.jcv.2004.06.010

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, De Backer G (2002) Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 160(2):457–463. https://doi.org/10.1016/S0021-9150(01)00602-5

    Article  PubMed  Google Scholar 

  30. 30.

    Liu SC, Tsai CT, Wu CK, Yu MF, Wu MZ, Lin LI, Wang SS, Hwang JJ, Tseng YZ, Chiang FT, Tseng CD (2009) Human parvovirus b19 infection in patients with coronary atherosclerosis. Arch Med Res 40(7):612–617. https://doi.org/10.1016/j.arcmed.2009.09.002

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Kerr JR, Barah F, Mattey DL, Laing I, Hopkins SJ, Hutchinson IV, Tyrrell DA (2001) Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 82(Pt 12):3011–3019. https://doi.org/10.1099/0022-1317-82-12-3011

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Lawson JS, Glenn WK, Tran DD, Ngan CC, Duflou JA, Whitaker NJ (2015) Identification of human papilloma viruses in atheromatous coronary artery disease. Front Cardiovasc Med 2:17. https://doi.org/10.3389/fcvm.2015.00017

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Bonin LR, Madden K, Shera K, Ihle J, Matthews C, Aziz S, Perez-Reyes N, McDougall JK, Conroy SC (1999) Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque. Arterioscler Thromb Vasc Biol 19(3):575–587. https://doi.org/10.1161/01.ATV.19.3.575

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    Tong DY, Wang XH, Xu CF, Yang YZ, Xiong SD (2005) Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 11(9):1292–1296. https://doi.org/10.3748/wjg.v11.i9.1292

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Targher G, Bertolini L, Padovani R, Rodella S, Arcaro G, Day C (2007) Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol 46(6):1126–1132. https://doi.org/10.1016/j.jhep.2007.01.021

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Nikolopoulou A, Tousoulis D, Antoniades C, Petroheilou K, Vasiliadou C, Papageorgiou N, Koniari K, Stefanadi E, Latsios G, Siasos G, Stefanadis C (2008) Common community infections and the risk for coronary artery disease and acute myocardial infarction: evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1. Int J Cardiol 130(2):246–250. https://doi.org/10.1016/j.ijcard.2007.08.052

    Article  PubMed  Google Scholar 

  37. 37.

    Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE (2000) The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 182(6):1583–1587. https://doi.org/10.1086/317613

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Costantini S, Capone F, Guerriero E, Maio P, Colonna G, Castello G (2010) Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis. Eur Cytokine Netw 21(4):251–256. https://doi.org/10.1684/ecn.2010.0214

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    Petta S, Torres D, Fazio G, Camma C, Cabibi D, Di Marco V, Licata A, Marchesini G, Mazzola A, Parrinello G, Novo S, Licata G, Craxi A (2012) Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations. Hepatology 55(5):1317–1323. https://doi.org/10.1002/hep.25508

    Article  PubMed  Google Scholar 

  40. 40.

    Oliveira CP, Kappel CR, Siqueira ER, Lima VM, Stefano JT, Michalczuk MT, Marini SS, Barbeiro HV, Soriano FG, Carrilho FJ, Pereira LM, Alvares-da-Silva MR (2013) Effects of hepatitis C virus on cardiovascular risk in infected patients: a comparative study. Int J Cardiol 164(2):221–226. https://doi.org/10.1016/j.ijcard.2011.07.016

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Marchesini G, Ronchi M, Forlani G, Bugianesi E, Bianchi G, Fabbri A, Zoli M, Melchionda N (1999) Cardiovascular disease in cirrhosis—a point-prevalence study in relation to glucose tolerance. Am J Gastroenterol 94(3):655–662. https://doi.org/10.1111/j.1572-0241.1999.00931.x

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    Auer J, Leitinger M, Berent R, Prammer W, Weber T, Lassnig E, Eber B (2002) Influenza A and B IgG seropositivity and coronary atherosclerosis assessed by angiography. Heart Dis 4(6):349–354. https://doi.org/10.1097/01.HDX.0000038560.97526.1D

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W (2003) Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice. Circulation 107(5):762–768. https://doi.org/10.1161/01.CIR.0000048190.68071.2B

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Van Lenten BJ, Wagner AC, Anantharamaiah G, Garber DW, Fishbein MC, Adhikary L, Nayak DP, Hama S, Navab M, Fogelman AM (2002) Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein AI mimetic peptide. Circulation 106(9):1127–1132. https://doi.org/10.1161/01.CIR.0000030182.35880.3E

    Article  PubMed  Google Scholar 

  45. 45.

    Kearns A, Gordon J, Burdo TH, Qin X (2017) HIV-1-associated atherosclerosis: unraveling the missing link. J Am Coll Cardiol 69(25):3084–3098. https://doi.org/10.1016/j.jacc.2017.05.012

    Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    D'Ascenzo F, Cerrato E, Calcagno A, Grossomarra W, Ballocca F, Omedè P, Montefusco A, Veglia S, Barbero U, Gili S (2015) High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. Atherosclerosis 240(1):197–204. https://doi.org/10.1016/j.atherosclerosis.2015.03.019

    CAS  Article  PubMed  Google Scholar 

  47. 47.

    Sosner P, Wangermez M, Chagneau-Derrode C, Le Moal G, Silvain C (2012) Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection. Atherosclerosis 222(1):274–277. https://doi.org/10.1016/j.atherosclerosis.2012.02.027

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    Duffy P, Wang X, Lin PH, Yao Q, Chen C (2009) HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial Cells1. J Surg Res 156(2):257–264. https://doi.org/10.1016/j.jss.2009.02.005

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Kwon TW, Kim DK, Ye JS, Lee WJ, Moon MS, Joo CH, Lee H, Kim YK (2004) Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J Microbiol 42(4):299–304

    CAS  PubMed  Google Scholar 

  50. 50.

    Guan XR, Jiang LX, Ma XH, Wang LF, Quan H, Li HY (2010) Respiratory syncytial virus infection and risk of acute myocardial infarction. Am J Med Sci 340(5):356–359. https://doi.org/10.1097/MAJ.0b013e3181eecf29

    Article  PubMed  Google Scholar 

  51. 51.

    Layegh P, Shoeibi A, Nikkhah K, Juibary AG, Raftari S, Darbarpanah S, Boroumand R, Azarpazhooh M (2014) Can HTLV-1 infection be a potential risk factor for atherosclerosis? Intervirology 57(6):365–368. https://doi.org/10.1159/000365785

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Leinonen M, Saikku P (2002) Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2(1):11–17. https://doi.org/10.1016/S1473-3099(01)00168-2

    Article  PubMed  Google Scholar 

  53. 53.

    Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C (2000) Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 102(7):779–785. https://doi.org/10.1161/01.CIR.102.7.779

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    Rosenfeld ME, Campbell LA (2011) Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 106(5):858–867. https://doi.org/10.1160/TH11-06-0392

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Jiang B, Hebert VY, Khandelwal AR, Stokes KY, Dugas TR (2009) HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model. Toxicol Lett 187(3):164–171. https://doi.org/10.1016/j.toxlet.2009.02.017

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. Jama 261(24):3561–3566. https://doi.org/10.1001/jama.1989.03420240075030

    CAS  Article  PubMed  Google Scholar 

  57. 57.

    Wang Z, Cai J, Zhang M, Wang X, Chi H, Feng H, Yang X (2016) Positive expression of human cytomegalovirus phosphoprotein 65 in atherosclerosis. Biomed Res Int 2016:4067685. https://doi.org/10.1155/2016/4067685

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  58. 58.

    Daus H, Ozbek C, Saage D, Scheller B, Schieffer H, Pfreundschuh M, Gause A (1998) Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 90(2):83–88. https://doi.org/10.1159/000006824

    CAS  Article  PubMed  Google Scholar 

  59. 59.

    Saetta A, Fanourakis G, Agapitos E, Davaris PS (2000) Atherosclerosis of the carotid artery; absence of evidence for CMV involvement in atheroma formation. Cardiovasc Pathol 9(3):181–183. https://doi.org/10.1016/S1054-8807(00)00040-5

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    Bason C, Corrocher R, Lunardi C, Puccetti P, Olivieri O, Girelli D, Navone R, Beri R, Millo E, Margonato A, Martinelli N, Puccetti A (2003) Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 362(9400):1971–1977. https://doi.org/10.1016/S0140-6736(03)15016-7

    CAS  Article  PubMed  Google Scholar 

  61. 61.

    Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Tinazzi E, Beri R, Corrocher R, Puccetti A (2007) Endothelial cells’ activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis. PLoS One 2(5):e473. https://doi.org/10.1371/journal.pone.0000473

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  62. 62.

    Zhang J, Liu Y-Y, Sun H-L, Li S, Xiong H-R, Yang Z-Q, Xiang G-D, Jiang X-J (2015) High human cytomegalovirus IgG level is associated with increased incidence of diabetic atherosclerosis in type 2 diabetes mellitus patients. Med Sci Monit 21:4102. https://doi.org/10.12659/MSM.896071

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Malkin JE (2004) Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(Suppl 1):2A–23A

    PubMed  Google Scholar 

  64. 64.

    Hechter RC, Budoff M, Hodis HN, Rinaldo CR, Jenkins FJ, Jacobson LP, Kingsley LA, Taiwo B, Post WS, Margolick JB (2012) Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study. Atherosclerosis 223(2):433–436. https://doi.org/10.1016/j.atherosclerosis.2012.03.002

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  65. 65.

    Young LS, Rickinson AB (2004) Epstein–Barr virus: 40 years on. Nat Rev Cancer 4(10):757–768. https://doi.org/10.1038/nrc1452

    CAS  Article  PubMed  Google Scholar 

  66. 66.

    Lobzin Iu V, Boitsov SA, Filippov AE, Linchak RM, Mangutov DA (2005) Effect of respiratory infections on the clinical course of coronary artery disease. Klin Med (Mosk) 83(11):22–26

    CAS  Google Scholar 

  67. 67.

    Takahashi M, Ito M, Sakamoto F, Shimizu N, Furukawa T, Takahashi M, Matsunaga Y (1995) Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol 22(2):168–172. https://doi.org/10.1111/j.1600-0560.1995.tb01402.x

    CAS  Article  PubMed  Google Scholar 

  68. 68.

    Nakazawa T, Tomosugi N, Sakamoto K, Asaka M, Yuri T, Ishikawa I, Kitagawa S (2000) Acute glomerulonephritis after human parvovirus B19 infection. Am J Kidney Dis 35(6):E31. https://doi.org/10.1016/S0272-6386(00)70070-9

    CAS  Article  PubMed  Google Scholar 

  69. 69.

    Kuo H-K, Fujise K (2011) Human papillomavirus and cardiovascular disease among US women in the National Health and Nutrition Examination Survey, 2003 to 2006. J Am Coll Cardiol 58(19):2001–2006. https://doi.org/10.1016/j.jacc.2011.07.038

    Article  PubMed  Google Scholar 

  70. 70.

    Foresta C, Bertoldo A, Garolla A, Pizzol D, Mason S, Lenzi A, De Toni L (2013) Human papillomavirus proteins are found in peripheral blood and semen Cd20+ and Cd56+ cells during Hpv-16 semen infection. BMC Infect Dis 13(1):593. https://doi.org/10.1186/1471-2334-13-593

    Article  PubMed  PubMed Central  Google Scholar 

  71. 71.

    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336(14):973–979. https://doi.org/10.1056/NEJM199704033361401

    CAS  Article  PubMed  Google Scholar 

  72. 72.

    Berk BC, Weintraub WS, Alexander RW (1990) Elevation of C-reactive protein in “active” coronary artery disease. Am J Cardiol 65(3):168–172. https://doi.org/10.1016/0002-9149(90)90079-G

    CAS  Article  PubMed  Google Scholar 

  73. 73.

    Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331(7):417–424. https://doi.org/10.1056/NEJM199408183310701

    CAS  Article  PubMed  Google Scholar 

  74. 74.

    Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC (1995) Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med 332(10):635–641. https://doi.org/10.1056/NEJM199503093321003

    CAS  Article  PubMed  Google Scholar 

  75. 75.

    Kuller LH, Tracy RP, Shaten J, Meilahn EN (1996) Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 144(6):537–547. https://doi.org/10.1093/oxfordjournals.aje.a008963

    CAS  Article  PubMed  Google Scholar 

  76. 76.

    Amirzadegan A, Davoodi G, Boroumand M, Darabyan S, Dehkordi M, Goodarzynejad H (2007) Association between hepatitis B surface antibody seropositivity and coronary artery disease. Indian J Med Sci 61(12):648

    Article  Google Scholar 

  77. 77.

    Ghotaslou R, Aslanabadi N, Ghojazadeh M (2008) Hepatitis B virus infection and the risk of coronary atherosclerosis. Ann Acad Med Singap 37(11):913–915

    PubMed  Google Scholar 

  78. 78.

    Sung J, Song YM, Choi YH, Ebrahim S, Davey Smith G (2007) Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction. Stroke 38(5):1436–1441. https://doi.org/10.1161/STROKEAHA.106.466268

    Article  PubMed  Google Scholar 

  79. 79.

    Adinolfi LE, Restivo L, Zampino R, Guerrera B, Lonardo A, Ruggiero L, Riello F, Loria P, Florio A (2012) Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis 221(2):496–502. https://doi.org/10.1016/j.atherosclerosis.2012.01.051

    CAS  Article  PubMed  Google Scholar 

  80. 80.

    Majumdar M, Ratho RK, Chawla Y, Singh MP (2015) Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E. J Clin Virol 73:8–13. https://doi.org/10.1016/j.jcv.2015.09.011

    CAS  Article  PubMed  Google Scholar 

  81. 81.

    Madjid M, Awan I, Ali M, Frazier L, Casscells W (2005) Influenza and atherosclerosis: vaccination for cardiovascular disease prevention. Expert Opin Biol Ther 5(1):91–96. https://doi.org/10.1517/14712598.5.1.91

    CAS  Article  PubMed  Google Scholar 

  82. 82.

    Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A (2011) Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 32(14):1730–1735. https://doi.org/10.1093/eurheartj/ehr004

    Article  PubMed  Google Scholar 

  83. 83.

    Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W (2000) Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102(25):3039–3045. https://doi.org/10.1161/01.CIR.102.25.3039

    CAS  Article  PubMed  Google Scholar 

  84. 84.

    Heffelfinger JD, Heckbert SR, Psaty BM, Weiss NS, Thompson WW, Bridges CB, Jackson LA (2006) Influenza vaccination and risk of incident myocardial infarction. Hum Vaccin 2(4):161–166. https://doi.org/10.4161/hv.2.4.2943

    Article  PubMed  Google Scholar 

  85. 85.

    Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE, Thompson WW (2002) Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 156(7):634–640. https://doi.org/10.1093/aje/kwf073

    Article  PubMed  Google Scholar 

  86. 86.

    Guan XR, Li X, Xin XM, Jiang LX, Cui LY, Wang LF, Li HY (2008) Influenza virus infection and risk of acute myocardial infarction. Inflammation 31(4):266–272. https://doi.org/10.1007/s10753-008-9074-2

    CAS  Article  PubMed  Google Scholar 

  87. 87.

    Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, Kowalska JD, de Wit S, Law M, el Sadr W, Kirk O, Friis-Moller N, Monforte A, Phillips AN, Sabin CA, Lundgren JD, Group DADS (2014) Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet 384(9939):241–248. https://doi.org/10.1016/S0140-6736(14)60604-8

    Article  PubMed  Google Scholar 

  88. 88.

    Lo J, Abbara S, Shturman L, Soni A, Wei J, Rocha-Filho JA, Nasir K, Grinspoon SK (2010) Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 24(2):243–253. https://doi.org/10.1097/QAD.0b013e328333ea9e

    Article  PubMed  PubMed Central  Google Scholar 

  89. 89.

    Zanni MV, Abbara S, Lo J, Wai B, Hark D, Marmarelis E, Grinspoon SK (2013) Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men. AIDS 27(8):1263–1272. https://doi.org/10.1097/QAD.0b013e32835eca9b

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  90. 90.

    Friis-Møller N, Weber R, Reiss P, Thiébaut R, Kirk O, Monforte AA, Pradier C, Morfeldt L, Mateu S, Law M (2003) Cardiovascular disease risk factors in HIV patients—association with antiretroviral therapy. Results from the DAD study. Aids 17(8):1179–1193. https://doi.org/10.1097/01.aids.0000060358.78202.c1

    Article  PubMed  Google Scholar 

  91. 91.

    Hansson GK, Robertson AK, Soderberg-Naucler C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297–329. https://doi.org/10.1146/annurev.pathol.1.110304.100100

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

This project was supported by the Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hossein Bannazadeh Baghi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of paper, formal consent does not apply.

Informed consent

For this type of paper, informed consent does not apply.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hemmat, N., Ebadi, A., Badalzadeh, R. et al. Viral infection and atherosclerosis. Eur J Clin Microbiol Infect Dis 37, 2225–2233 (2018). https://doi.org/10.1007/s10096-018-3370-z

Download citation

Keywords

  • Viral infection
  • Atherosclerosis
  • Inflammation